With a half-life of 5 days, tirzepatide is administered once weekly, on the same day each week, regardless of meals
Importantly, despite the dramatic decrease in the level of labeled M3 C3 in healthy and MMA hepatocytes treated with BCATi (Figure 3D), treatment with the inhibitor had no significant effect on the concentration of the unlabeled pool of C3 (M0 C3, Figure 3E) or the concentration of the total pool of C3 (M3 C3 + M0 C3 = total C3, Figure 3F) in healthy or MMA hepatocytes exposed to [ 15 N, 13 C 5 ]valine
Among these firms that do not cover GLP-1 agonists for weight loss, 18% say that covering these medications for weight loss is very important for employee satisfaction, 27% say that it is important, 36% say it is slightly important, 13% say that it is not important, and 6% do not know the answer to this question
Maniam J, Antoniadis CP, Le V, Morris MJ
TRIUMPH-1 Results: Encouraging Findings Promising results from the TRIUMPH-1 Phase 3 trial show that participants taking Retatrutide lost up to 28.3% of their body weight over 80 weeks